Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders
Stanley I. Martin(Brigham and Women's Hospital), Lindsey R. Baden(Brigham and Women's Hospital), Francisco M. Marty(Brigham and Women's Hospital), Karen Fiumara, John G. Gribben(Queen Mary University of London), Steven P. Treon(Dana-Farber Cancer Institute)
Cited by 270
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k